Physician profile
Tabitha J Bane
NPI 1417339896
$231.84
in general payments reported to CMS, 2019-2025
10 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23.87 · 2022: $18.42 · 2024: $72.90 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $170 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $169.55 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $72.53 | 2024-2025 | |
| Novo Nordisk INC | $25.99 | 2025 | Wegovy |
| Abbott Laboratories | $23.71 | 2025 | Freestyle Libre 3 |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Livanova USA, INC. | $18.42 | 2022 | |
| Neurocrine Biosciences, INC. | $17.94 | 2024 | Ingrezza |
| Lilly USA, LLC | $15.85 | 2024 | Amyvid |
| Ibsa Pharma INC. | $13.53 | 2025 | Tirosint, Licart, Flector |
| Medtronic, INC. | $12.52 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tabitha Bane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.